Literature DB >> 9727411

In vivo cell tracking by scanning laser ophthalmoscopy: quantification of leukocyte kinetics.

P Hossain1, J Liversidge, M J Cree, A Manivannan, P Vieira, P F Sharp, G C Brown, J V Forrester.   

Abstract

PURPOSE: To image peripheral blood leukocyte traffic in the normal retinal and choroidal vasculature and to quantify the differences in the circulation dynamics between normal and concanavalin A (ConA)-activated leukocytes.
METHODS: Normal or ConA-activated splenocytes were fluorescently labeled in vitro with 6-carboxyfluorescein diacetate (CFDA) and reinfused in vivo where they were tracked in the retinal and choroidal circulations of syngeneic rats by means of a scanning laser ophthalmoscope (SLO). Simultaneous digital and video images were captured for as long as 30 minutes, and the initial 15 seconds of image sequences and leukocyte dynamics were analyzed from digitized images by recording the velocity of trafficking cells and the number of stationary cells that accumulated with time, using a customized software package.
RESULTS: Mean velocity (+/-SD) was 29.8 +/- 15.3 mm/sec in the retinal arteries, 14.7 +/- 7.2 mm/sec in the retinal veins, and 3.0 +/- 3.6 mm/sec in the retinal capillaries. Mean velocity in the choroidal vessels was 6.1 +/- 6.0 mm/sec. No significant difference in leukocyte velocity was found between activated and normal leukocytes in any of the vessel systems. However, activated leukocytes were observed to accumulate more within the choroidal vasculature (P < 0.001) and the retinal capillaries (P < 0.001) than in control animals, but not in larger retinal vessels.
CONCLUSIONS: A technique to measure the kinetics of circulating leukocytes in vivo has been developed. Although leukocyte activation itself is insufficient to cause slowing of leukocyte velocity, the data indicate that leukocyte adherence to endothelium can be induced in the absence of local or systemic activating stimuli.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727411

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Laser imaging of the retina.

Authors:  P F Sharp; A Manivannan; P Vieira; J H Hipwell
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 2.  Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.

Authors:  A D Dick; J D Isaacs
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 3.  Scanning laser ophthalmoscopy and fundus fluorescent leucocyte angiography.

Authors:  P Hossain
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

4.  Fluorescent Dye Labeling of Erythrocytes and Leukocytes for Studying the Flow Dynamics in Mouse Retinal Circulation.

Authors:  Rupesh Agrawal; Praveen Kumar Balne; Sai Bo Bo Tun; Yeo Sia Wey; Neha Khandelwal; Veluchamy A Barathi
Journal:  J Vis Exp       Date:  2017-07-03       Impact factor: 1.355

5.  Retinal vasculature of adult zebrafish: in vivo imaging using confocal scanning laser ophthalmoscopy.

Authors:  Brent A Bell; Jing Xie; Alex Yuan; Charles Kaul; Joe G Hollyfield; Bela Anand-Apte
Journal:  Exp Eye Res       Date:  2014-10-24       Impact factor: 3.467

6.  The adult zebrafish retina: In vivo optical sectioning with Confocal Scanning Laser Ophthalmoscopy and Spectral-Domain Optical Coherence Tomography.

Authors:  Brent A Bell; Alex Yuan; Rose M Dicicco; Joseph Fogerty; Emma M Lessieur; Brian D Perkins
Journal:  Exp Eye Res       Date:  2016-10-06       Impact factor: 3.467

7.  A simple method for in vivo labelling of infiltrating leukocytes in the mouse retina using indocyanine green dye.

Authors:  Dawn A Sim; Colin J Chu; Senthil Selvam; Michael B Powner; Sidath Liyanage; David A Copland; Pearse A Keane; Adnan Tufail; Catherine A Egan; James W B Bainbridge; Richard W Lee; Andrew D Dick; Marcus Fruttiger
Journal:  Dis Model Mech       Date:  2015-08-20       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.